Upcoming Sessions

The attendees will understand the fundamental aspects of making the diagnosis with a special emphasis on identifying the young infant and toddler for more intensive monitoring. The presentation reviews the epidemiology, associated conditions, and the approach to management

How to say “NO” to those who seek the inappropriate: medication, disability, redundant testing, etc.

Please note this is a 90 minute session

Sports Physicals are designed to make sure that exercise is safe for individuals practicing sports. Providers are often asked to complete Pre-Participation-Evaluations (PPE) to identify unknown cardiac disease to prevent sudden death in competitive athletes. We will briefly review the rare severe cardiac complications that can occur in athletes after COVID-19. How to detect these rare complications, what test to order, when to refer for further evaluation and how to assess when it is safe to return to play will be discussed.

How to best approach this common symptom in terms of both diagnosis and treatment? Understand key components of the history, the role of drugs both in terms of causation and treatment, non arrhythmic etiologies, risk stratification, and when to refer either to the emergency room or to a cardiac specialist.

Continuous glucose monitoring (CGM) has transformed the way we take care of individuals with diabetes. During this session, participants will learn how to use the rich continuous glucose data set from the CGM to optimize treatment regimens and facilitate lifestyle change in their patients. Learn how a CGM works, how it can be used to prevent hypoglycemia, how to interpret the CGM data and discuss the clinical evidence and outcomes associated with use of CGM.

We will review the pathophysiologic spectrum of inflammatory conditions affecting the lactating breast in the mastitis spectrum. We start with discussing hyperlactation (“oversupply”) and will transition into exploring non-infectious and infectious mastitis, and abscess development in the setting of massage and untreated hyperlactation. We will also detail the identification and treatment of galactocele and lactational phlegmon. We will review risk factors for these conditions and how healthcare providers can help prevent progression of complications. These include techniques such as gentle lymphatic drainage and other supportive measures such as reducing excessive pumping.

After this session participants will be able to define resistant hypertension, have a clearer understanding of when to screen for secondary causes of hypertension, and be informed of the changing understanding of the frequency of primary hyperaldosteronism.